Oncology Pharma Inc. (ONPH)
OTCMKTS · Delayed Price · Currency is USD
0.0523
+0.0013 (2.55%)
At close: Aug 20, 2026
Oncology Pharma Market Cap
Oncology Pharma has a market cap or net worth of $2.02 million as of August 21, 2026. Its market cap has increased by 26,048.79% in one year.
Market Cap
2.02M
Enterprise Value
n/a
Revenue
10.21K
Ranking
n/a
PE Ratio
10.87
Stock Price
$0.05
ChartMarket Cap Chart
Since April 1, 2016, Oncology Pharma's market cap has increased from 27.10K to 2.02M, an increase of 7,361.57%. That is a compound annual growth rate of 51.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 2.02M | 1,207.50% |
| Dec 31, 2025 | 154.65K | 3,900.34% |
| Dec 31, 2024 | 3.87K | -50.01% |
| Dec 29, 2023 | 7.73K | -99.94% |
| Dec 30, 2022 | 13.06M | -90.45% |
| Dec 31, 2021 | 136.74M | 1,159.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enterra | 3.22M |
| Blue Star Global | 3.16M |
| Chase Packaging | 3.09M |
| ZhongMin Mei-Hao Holding Co | 3.02M |
| Aimrite Holdings | 2.80M |
| Eastern Asteria | 2.78M |
| Affiliated Resources | 2.61M |
| Lifeline Biotechnologies | 2.61M |